57th Annual TB Course (Virtual Series)

57th Annual TB Course (Virtual Series)
View full list of Professional Education courses.

Since the introduction of effective chemotherapy, many changes have come about in the management of tuberculosis (TB). Most important have been the shift from sanatoria-based to general hospital and clinic-based treatment and the knowledge that active disease can reliably be prevented among those who are latently infected. With the development of effective drugs for TB, the significant advances in bacteriology, and increased knowledge about the treatment of latent TB infection, the approach to tuberculosis control has become increasingly sophisticated.

The 57th Annual TB Course (Virtual Series) provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.


Course Highlights:

  • Epidemiology of tuberculosis

  • Transmission and pathogenesis

  • Diagnosis and treatment of tuberculosis including MDR/XDR-TB

  • Diagnosis and treatment of latent tuberculosis infection

  • Emphasis on vulnerable populations such as pediatric and HIV co-infection

  • Interactive Contact Investigation Workshop

Registered attendees get access to the recorded sessions for 6 months.

 

Learning Objectives:

  • Discuss the epidemiological features which are associated with increased risk for tuberculosis.

  • Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.

  • Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.

  • Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen.

  • Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.

The 57th Annual TB Course will follow a new format in 2021, with weekly virtual presentations led by expert faculty from April 2 – May 7, 2021. After the virtual presentation each week, registered attendees will have access to the recorded sessions. Registrants who miss a live session can claim credit for viewing the recorded session when it becomes available. 

All recorded sessions will be available to registered attendees through October 31, 2021. 

 

Topics and Speakers*:

Friday, April 2, 11:00 a.m. -12:15 p.m. (MST)  These recorded sessions are now available to registrants.
 


Epidemiology
Randall Reves, MD
Professor, Infectious Diseases and Epidemiology 
University of Colorado Denver School of Medicine
University of Colorado School of Public Health

 
Clinical Presentation and Imaging
Shannon Kasperbauer, MD  (Program Co-Director)
Associate Professor of Medicine 
Division of Mycobacterial and Respiratory Infections  
National Jewish Health  
University of Colorado Health Sciences Center 
 
 

Friday, April 9, 11:00 a.m. -12:15 p.m. (MST)  These recorded sessions are now available to registrants.
 
Laboratory Services
Reeti Khare, PhD
Director, Infectious Disease Laboratory
Advanced Diagnostic Laboratories
National Jewish Health
 
Diagnosis of LTBI
Robert Belknap, MD
Medical Director, Denver Metro TB Control Program
Associate Professor, Division of Infectious Diseases
Denver Health and University of Colorado
 

Friday, April 16, 11:00 a.m. -12:15 p.m. (MST)  These recorded sessions are now available to registrants.
 
Treatment of Drug Susceptible TB
David Griffith, MD
Professor of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health

 

  Treatment of Drug-Resistant TB
Charles Daley, MD (Program Co-Director)
Chief, Division of Mycobacterial and Respiratory Infections  
Professor of Medicine, National Jewish Health 
University of Colorado Denver 
 

Friday, April 23, 11:00 a.m. -12:15 p.m. (MST) These recorded sessions are now available to registrants.
 
Treatment of LTBI
Nicholas Walter, MD
Associate Professor of Medicine
Pulmonary Sciences and Critical Care Medicine
University of Colorado
 
Monitoring and Management of Side Effects
Gwen Huitt, MD
Professor of Medicine, Division of Mycobacterial and Respiratory Infections
National Jewish Health  
Associate Professor of Medicine, Division of Infectious Diseases
University of Colorado Denver 
 

Friday, April 30, 11:00 a.m. -12:15 p.m. (MST)  Includes 15 minutes for Q&A discussion
 
TB and HIV Co-infection
Michelle Haas, MD
Associate Director, Denver Metro TB Program at Denver Public Health
Assistant Professor, Division of Infectious Diseases 
University of Colorado Anschutz Medical Campus
 
Pediatric TB
James Gaensbauer, MD
Assistant Professor of Pediatrics
Section of Pediatrics Infectious Diseases
University of Colorado, School of Medicine
Pediatric Consultant, Denver Metro Tuberculosis Clinic
 
​​
Friday, May 7, 11:00 a.m. -12:00 p.m. (MST)
  Contact Investigation Workshop with Q&A discussion
Robert Belknap, MD
Medical Director, Denver Metro TB Control Program
Associate Professor, Division of Infectious Diseases
Denver Health and University of Colorado

 

*Agenda is subject to change.

Registration Fees:

The following fees include access to all live sessions and the recordings through October 31, 2021, as well as CME/CNE credit for courses viewed.

$225 General
$135 Military, Fellow and Resident*
$50 National Jewish Health Staff

* Verification of Fellowship Status Form (required)

To pay now, please fill out the registration form below. To make payment arrangements, please contact ProEd@njhealth.org.
 

If you are having problems registering, please call 800.844.2305 or 303.398.1000 or email proed@njhealth.org.



* Indicates required field

Contact Information

Additional Information

Fees



Registration Fee
$225.00

For other payment arrangements, please contact ProEd@njhealth.org.

Accreditation and Designation Statements

Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 7.25 contact hours.